Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
for CKD Stage 3
Sites in Greenville +4 more locations
Sponsor: OPKO Health, Inc.
Sex: All·Age: 1 Month - 17
Code: NCT07494045·Phase 2·Recruiting·Listed Mar 2026